No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 12.180
- +0.100+0.83%
Close Dec 20 16:00 ET
- 12.446
- +0.266+2.18%
Post 20:01 ET
1.24BMarket Cap-2.23P/E (TTM)
12.450High11.850Low3.69MVolume11.940Open12.080Pre Close45.02MTurnover3.67%Turnover RatioLossP/E (Static)101.85MShares34.87052wk High1.29P/B1.22BFloat Cap11.79052wk Low--Dividend TTM100.57MShs Float202.730Historical High--Div YieldTTM4.97%Amplitude9.180Historical Low12.213Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Will Intellia Therapeutics (NASDAQ:NTLA) Spend Its Cash Wisely?
Why Intellia Therapeutics (NTLA) Is the Worst ARK Stock to Buy According to Short Sellers
Lilly Tops Morgan Stanley's Biopharma Pick List for 2025
Express News | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Heat List
US
Overall
Symbol
Price
% Chg
No Data
